Table 3.
Values of variables associated with survival at 1-year follow-up evaluations in untreated vs. diflunisal-treated ATTRwt patients
Variable, median (range) | Untreated (n = 23) | Diflunisal-treated (n = 12) | P |
---|---|---|---|
TTR (mg/dL) | 22 (12 – 29) | 30 (25 – 43) | < 0.001 |
cTn-I (ng/mL) | 0.096 (0.021 – 0.376) | 0.058 (0.006 – 0.328) | 0.008 |
ATTRwt indicates wild-type transthyretin amyloidosis; TTR, transthyretin; and, cTn-I, cardiac troponin I